AU6832200A - Moraxella cattarrhalis basb114 antigens and uses thereof - Google Patents

Moraxella cattarrhalis basb114 antigens and uses thereof

Info

Publication number
AU6832200A
AU6832200A AU68322/00A AU6832200A AU6832200A AU 6832200 A AU6832200 A AU 6832200A AU 68322/00 A AU68322/00 A AU 68322/00A AU 6832200 A AU6832200 A AU 6832200A AU 6832200 A AU6832200 A AU 6832200A
Authority
AU
Australia
Prior art keywords
cattarrhalis
basb114
moraxella
antigens
moraxella cattarrhalis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU68322/00A
Other languages
English (en)
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10858278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU6832200(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Publication of AU6832200A publication Critical patent/AU6832200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU68322/00A 1999-07-30 2000-07-27 Moraxella cattarrhalis basb114 antigens and uses thereof Abandoned AU6832200A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9917977 1999-07-30
GBGB9917977.2A GB9917977D0 (en) 1999-07-30 1999-07-30 Novel compounds
PCT/EP2000/007293 WO2001009179A1 (en) 1999-07-30 2000-07-27 Moraxella cattarrhalis basb114 antigens and uses thereof

Publications (1)

Publication Number Publication Date
AU6832200A true AU6832200A (en) 2001-02-19

Family

ID=10858278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU68322/00A Abandoned AU6832200A (en) 1999-07-30 2000-07-27 Moraxella cattarrhalis basb114 antigens and uses thereof

Country Status (8)

Country Link
EP (1) EP1204678A1 (ja)
JP (1) JP2003506027A (ja)
CN (1) CN1367790A (ja)
AU (1) AU6832200A (ja)
CA (1) CA2380295A1 (ja)
GB (1) GB9917977D0 (ja)
HK (1) HK1047943A1 (ja)
WO (1) WO2001009179A1 (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7154936B2 (en) * 2001-12-03 2006-12-26 Qualcomm, Incorporated Iterative detection and decoding for a MIMO-OFDM system
WO2004015099A2 (en) 2002-08-02 2004-02-19 Glaxosmithkline Biologicals Sa Vaccine composition comprising lipooligosaccharide with reduced phase variability
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440425B1 (en) * 1995-05-01 2002-08-27 Aventis Pasteur Limited High molecular weight major outer membrane protein of moraxella

Also Published As

Publication number Publication date
CN1367790A (zh) 2002-09-04
JP2003506027A (ja) 2003-02-18
CA2380295A1 (en) 2001-02-08
GB9917977D0 (en) 1999-09-29
HK1047943A1 (zh) 2003-03-14
WO2001009179A1 (en) 2001-02-08
EP1204678A1 (en) 2002-05-15

Similar Documents

Publication Publication Date Title
AU1290001A (en) Antibodies
IL223047A (en) Antibodies containing fc region and their uses
AU3731600A (en) Composition and structures made therefrom
AU7989400A (en) Compounds and methods
AU6058500A (en) Fusion protein and uses thereof
AU1951201A (en) Peptide antigens
AU3215500A (en) Compounds and methods
AU4935000A (en) Antibodies
GB9927332D0 (en) Novel antibody and uses thereof
AU9781998A (en) Huchordin and uses thereof
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
AU4198299A (en) Compounds and uses thereof
AU3753599A (en) Micro-compartmentalization device and uses thereof
AU3159499A (en) Antigen preparation and use
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AUPQ342599A0 (en) Conjugates and uses thereof
AU6232300A (en) Receptors and associated proteins
AU2841801A (en) Triazolotriazinones and the use thereof
AU4776800A (en) Acetylcholinesterase-derived peptides and uses thereof
AU1083501A (en) Antibiotic-metal complex and methods
AU3283500A (en) Tumor-associated antigen
AUPP363498A0 (en) Antigens and their detection
AU6150100A (en) Separating device and use thereof
AU6832200A (en) Moraxella cattarrhalis basb114 antigens and uses thereof
AU2136401A (en) P450rai-2 and related proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase